EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 34.65 Million EUR | 17.51% |
| 2022 | 29.49 Million EUR | 8.53% |
| 2021 | 27.17 Million EUR | -6.13% |
| 2020 | 28.94 Million EUR | 12.58% |
| 2019 | 25.71 Million EUR | 8.13% |
| 2018 | 23.77 Million EUR | 9.37% |
| 2017 | 21.73 Million EUR | -1.81% |
| 2016 | 22.14 Million EUR | -8.33% |
| 2015 | 24.15 Million EUR | 41.96% |
| 2014 | 17.01 Million EUR | -3.28% |
| 2013 | 17.59 Million EUR | -21.06% |
| 2012 | 22.28 Million EUR | -6.52% |
| 2011 | 23.83 Million EUR | -11.84% |
| 2010 | 27.03 Million EUR | -2.74% |
| 2009 | 27.79 Million EUR | 4.23% |
| 2008 | 26.67 Million EUR | -12.7% |
| 2007 | 30.55 Million EUR | 131.93% |
| 2006 | 13.17 Million EUR | 15.4% |
| 2005 | 11.41 Million EUR | 14.96% |
| 2004 | 9.92 Million EUR | -23.18% |
| 2003 | 12.92 Million EUR | 13.16% |
| 2002 | 11.42 Million EUR | -19.73% |
| 2001 | 14.22 Million EUR | -9.08% |
| 2000 | 15.65 Million EUR | -25.44% |
| 1999 | 20.99 Million EUR | 2.58% |
| 1998 | 20.46 Million EUR | 19.74% |
| 1997 | 17.09 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 34.55 Million EUR | -4.41% |
| 2024 Q1 | 36.12 Million EUR | 4.24% |
| 2023 Q2 | 32.11 Million EUR | -5.02% |
| 2023 FY | 34.65 Million EUR | 17.51% |
| 2023 Q4 | 34.65 Million EUR | 4.44% |
| 2023 Q1 | 33.81 Million USD | 14.66% |
| 2023 Q3 | 33.18 Million EUR | 3.32% |
| 2022 FY | 29.49 Million EUR | 8.53% |
| 2022 Q4 | 29.49 Million EUR | -3.49% |
| 2022 Q2 | 29.02 Million EUR | 13.01% |
| 2022 Q1 | 25.68 Million EUR | -5.47% |
| 2022 Q3 | 30.55 Million EUR | 5.27% |
| 2021 Q1 | 26.44 Million EUR | -8.64% |
| 2021 FY | 27.17 Million EUR | -6.13% |
| 2021 Q2 | 26.43 Million EUR | -0.05% |
| 2021 Q4 | 27.17 Million EUR | 5.95% |
| 2021 Q3 | 25.64 Million EUR | -2.97% |
| 2020 FY | 28.94 Million EUR | 12.58% |
| 2020 Q4 | 28.94 Million EUR | 9.26% |
| 2020 Q1 | 16.66 Million EUR | -35.18% |
| 2020 Q2 | 14.84 Million EUR | -10.92% |
| 2020 Q3 | 26.49 Million EUR | 78.46% |
| 2019 Q1 | 16.83 Million EUR | -29.18% |
| 2019 Q2 | 16.35 Million EUR | -2.85% |
| 2019 FY | 25.71 Million EUR | 8.13% |
| 2019 Q4 | 25.71 Million EUR | 47.23% |
| 2019 Q3 | 17.46 Million EUR | 6.76% |
| 2018 Q2 | 22.13 Million EUR | 59.86% |
| 2018 FY | 23.77 Million EUR | 9.37% |
| 2018 Q1 | 13.84 Million EUR | -36.32% |
| 2018 Q4 | 23.77 Million EUR | 68.72% |
| 2018 Q3 | 14.09 Million EUR | -36.32% |
| 2017 FY | 21.73 Million EUR | -1.81% |
| 2017 Q3 | 12.67 Million EUR | -37.54% |
| 2017 Q4 | 21.73 Million EUR | 71.5% |
| 2017 Q1 | 14.05 Million EUR | -36.53% |
| 2017 Q2 | 20.29 Million EUR | 44.43% |
| 2016 Q2 | 22.33 Million EUR | 30.48% |
| 2016 Q1 | 17.11 Million EUR | -29.12% |
| 2016 FY | 22.14 Million EUR | -8.33% |
| 2016 Q4 | 22.14 Million EUR | 52.2% |
| 2016 Q3 | 14.54 Million EUR | -34.87% |
| 2015 Q3 | 12.57 Million EUR | -38.74% |
| 2015 Q4 | 24.15 Million EUR | 92.13% |
| 2015 Q1 | 12.02 Million EUR | -29.34% |
| 2015 FY | 24.15 Million EUR | 41.96% |
| 2015 Q2 | 20.51 Million EUR | 70.69% |
| 2014 Q1 | 12.11 Million EUR | -31.11% |
| 2014 Q4 | 17.01 Million EUR | 46.39% |
| 2014 FY | 17.01 Million EUR | -3.28% |
| 2014 Q3 | 11.62 Million EUR | -45.44% |
| 2014 Q2 | 21.3 Million EUR | 75.81% |
| 2013 Q2 | 17.03 Million EUR | 38.57% |
| 2013 FY | 17.59 Million EUR | -21.06% |
| 2013 Q4 | 17.59 Million EUR | 66.01% |
| 2013 Q3 | 10.59 Million EUR | -37.79% |
| 2013 Q1 | 12.29 Million EUR | -44.84% |
| 2012 Q3 | 15.98 Million EUR | -25.04% |
| 2012 Q2 | 21.32 Million EUR | 55.14% |
| 2012 FY | 22.28 Million EUR | -6.52% |
| 2012 Q4 | 22.28 Million EUR | 39.41% |
| 2012 Q1 | 13.74 Million EUR | -42.34% |
| 2011 Q1 | 13.81 Million EUR | -48.91% |
| 2011 Q2 | 22.09 Million EUR | 59.97% |
| 2011 Q3 | 16.56 Million EUR | -25.02% |
| 2011 Q4 | 23.83 Million EUR | 43.87% |
| 2011 FY | 23.83 Million EUR | -11.84% |
| 2010 Q2 | 28.92 Million EUR | 116.84% |
| 2010 Q1 | 13.34 Million EUR | -52.01% |
| 2010 FY | 27.03 Million EUR | -2.74% |
| 2010 Q4 | 27.03 Million EUR | 0.0% |
| 2009 FY | 27.79 Million EUR | 4.23% |
| 2009 Q3 | 19.19 Million EUR | -25.88% |
| 2009 Q1 | 21.25 Million EUR | -20.29% |
| 2009 Q2 | 25.9 Million EUR | 21.84% |
| 2009 Q4 | 27.79 Million EUR | 44.79% |
| 2008 FY | 26.67 Million EUR | -12.7% |
| 2008 Q2 | 22.81 Million EUR | 0.0% |
| 2008 Q3 | 18.98 Million EUR | -16.77% |
| 2008 Q4 | 26.67 Million EUR | 40.47% |
| 2007 Q4 | 30.55 Million EUR | 99.44% |
| 2007 FY | 30.55 Million EUR | 131.93% |
| 2007 Q3 | 15.31 Million EUR | 0.0% |
| 2006 Q1 | 9.68 Million EUR | -15.12% |
| 2006 Q3 | 11.82 Million EUR | -3.36% |
| 2006 Q2 | 12.23 Million EUR | 26.29% |
| 2006 FY | 13.17 Million EUR | 15.4% |
| 2006 Q4 | 13.17 Million EUR | 11.4% |
| 2005 Q2 | 10.09 Million EUR | 5.65% |
| 2005 Q4 | 11.41 Million EUR | 0.0% |
| 2005 Q1 | 9.55 Million EUR | -3.83% |
| 2005 FY | 11.41 Million EUR | 14.96% |
| 2004 Q2 | 9.88 Million EUR | -6.53% |
| 2004 FY | 9.92 Million EUR | -23.18% |
| 2004 Q3 | 8.83 Million EUR | -10.63% |
| 2004 Q4 | 9.92 Million EUR | 12.46% |
| 2004 Q1 | 10.57 Million EUR | -18.23% |
| 2003 Q2 | 9.3 Million EUR | 3.91% |
| 2003 Q3 | 9.64 Million EUR | 3.66% |
| 2003 Q4 | 12.92 Million EUR | 34.09% |
| 2003 Q1 | 8.95 Million EUR | -21.64% |
| 2003 FY | 12.92 Million EUR | 13.16% |
| 2002 Q2 | 10.74 Million EUR | 4.07% |
| 2002 FY | 11.42 Million EUR | -19.73% |
| 2002 Q3 | 40.73 Million EUR | 279.27% |
| 2002 Q4 | 11.42 Million EUR | -71.96% |
| 2002 Q1 | 10.32 Million EUR | -27.48% |
| 2001 Q3 | 13.27 Million EUR | 4.74% |
| 2001 Q1 | 15.5 Million EUR | -0.96% |
| 2001 Q2 | 12.67 Million EUR | -18.26% |
| 2001 Q4 | 14.22 Million EUR | 7.23% |
| 2001 FY | 14.22 Million EUR | -9.08% |
| 2000 FY | 15.65 Million EUR | -25.44% |
| 2000 Q2 | 19.87 Million EUR | 3.22% |
| 2000 Q3 | 20.99 Million EUR | 5.64% |
| 2000 Q4 | 15.65 Million EUR | -25.44% |
| 2000 Q1 | 19.25 Million EUR | -8.3% |
| 1999 Q4 | 20.99 Million EUR | 0.0% |
| 1999 FY | 20.99 Million EUR | 2.58% |
| 1998 FY | 20.46 Million EUR | 19.74% |
| 1998 Q4 | 20.46 Million EUR | 0.0% |
| 1997 FY | 17.09 Million EUR | 0.0% |
| 1997 Q4 | 17.09 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 703.48 Million USD | 95.074% |
| Nemaura Medical Inc. | 26.37 Million USD | -31.38% |
| NeuroPace, Inc. | 86.99 Million USD | 60.166% |
| LENSAR, Inc. | 22.4 Million USD | -54.646% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -36.098% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 32.922% |
| Apyx Medical Corporation | 52.31 Million USD | 33.762% |
| Cutera, Inc. | 518.12 Million USD | 93.311% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -18.162% |
| BioSig Technologies, Inc. | 4.68 Million USD | -639.692% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 32.387% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.421% |
| Axonics, Inc. | 82.35 Million USD | 57.923% |
| IRIDEX Corporation | 24.91 Million USD | -39.097% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 72.045% |
| TELA Bio, Inc. | 59.16 Million USD | 41.429% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1970.164% |
| RxSight, Inc. | 22.18 Million USD | -56.186% |
| Align Technology, Inc. | 2.45 Billion USD | 98.587% |
| INVO Bioscience, Inc. | 19.99 Million USD | -73.316% |
| electroCore, Inc. | 8.94 Million USD | -287.418% |
| Telesis Bio, Inc. | 40.87 Million USD | 15.214% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 15.042% |
| Quipt Home Medical Corp. | 136.29 Million USD | 74.573% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 40.626% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -870.172% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -17.151% |
| Dynatronics Corporation | 11.78 Million USD | -194.178% |
| Modular Medical, Inc. | 2.27 Million USD | -1425.288% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -752.72% |
| Talis Biomedical Corporation | 29.22 Million USD | -18.582% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1326.524% |
| InMode Ltd. | 75.91 Million USD | 54.35% |
| Envoy Medical, Inc. | 9.4 Million USD | -268.587% |
| Bruker Corporation | 2.83 Billion USD | 98.778% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -548.719% |
| DexCom, Inc. | 4.19 Billion USD | 99.174% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -8048.624% |
| PAVmed Inc | 57.13 Million USD | 39.348% |
| Viveve Medical, Inc. | 10.84 Million USD | -219.485% |
| Cerus Corporation | 144.3 Million USD | 75.985% |
| Movano Inc. | 5.97 Million USD | -480.284% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 66.871% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -8048.624% |
| IceCure Medical Ltd | 4.24 Million USD | -715.977% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 94.577% |
| enVVeno Medical Corporation | 2.43 Million USD | -1323.185% |
| 908 Devices Inc. | 37.49 Million USD | 7.563% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -61.274% |
| Orthofix Medical Inc. | 326.58 Million USD | 89.389% |
| Surmodics, Inc. | 65.82 Million USD | 47.352% |
| Nuwellis, Inc. | 6.78 Million USD | -411.129% |
| Outset Medical, Inc. | 190.91 Million USD | 81.848% |
| Venus Concept Inc. | 107.1 Million USD | 67.644% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 84.463% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 69.593% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -49.799% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1297.558% |
| Inogen, Inc. | 121.38 Million USD | 71.45% |
| IRadimed Corporation | 20.73 Million USD | -67.123% |
| MaxCyte, Inc. | 36.1 Million USD | 4.023% |
| Pulmonx Corporation | 60.63 Million USD | 42.848% |
| PAVmed Inc. | 57.13 Million USD | 39.348% |
| iCAD, Inc. | 8 Million USD | -333.128% |
| OrthoPediatrics Corp. | 72.56 Million USD | 52.241% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -189.8% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -989.1% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1775.337% |
| SI-BONE, Inc. | 61.05 Million USD | 43.236% |
| Semler Scientific, Inc. | 6.27 Million USD | -452.704% |
| Beyond Air, Inc. | 29.77 Million USD | -16.388% |
| FONAR Corporation | 57.45 Million USD | 39.687% |
| AxoGen, Inc. | 101.16 Million USD | 65.744% |
| Biotricity, Inc. | 35.91 Million USD | 3.521% |
| Cytosorbents Corporation | 29.98 Million USD | -15.571% |
| ZimVie Inc. | 795.85 Million USD | 95.646% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 60.528% |
| Inari Medical, Inc. | 209.32 Million USD | 83.445% |
| UFP Technologies, Inc. | 118.04 Million USD | 70.643% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -189.8% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -173.075% |
| Sight Sciences, Inc. | 46.43 Million USD | 25.371% |
| Insulet Corporation | 1.85 Billion USD | 98.132% |
| Profound Medical Corp. | 12.66 Million USD | -173.606% |
| Bioventus Inc. | 589.79 Million USD | 94.124% |
| InspireMD, Inc. | 8.14 Million USD | -325.627% |
| BrainsWay Ltd. | 15.31 Million USD | -126.293% |
| BIOLASE, Inc. | 35.34 Million USD | 1.962% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1485.431% |
| Tenon Medical, Inc. | 5.56 Million USD | -522.5% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1847.979% |
| CVRx, Inc. | 39.28 Million USD | 11.78% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.901% |
| Sintx Technologies, Inc. | 6.59 Million USD | -425.626% |
| Acutus Medical, Inc. | 54.83 Million USD | 36.807% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -235.832% |
| NanoVibronix, Inc. | 2.68 Million USD | -1190.192% |
| Quanterix Corporation | 78.08 Million USD | 55.619% |
| LivaNova PLC | 1.15 Billion USD | 96.992% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -96.52% |
| Varex Imaging Corporation | 668.6 Million USD | 94.817% |
| Vivani Medical, Inc. | 25.03 Million USD | -38.419% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -870.172% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -609.407% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 96.683% |
| TransMedics Group, Inc. | 568.84 Million USD | 93.908% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -107.736% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2499.499% |
| Spectral AI, Inc. | 12.4 Million USD | -179.45% |
| Hyperfine, Inc. | 9.8 Million USD | -253.618% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 86.152% |
| Biomerica, Inc. | 2.66 Million USD | -1201.335% |
| Bone Biologics Corporation | 831.4 Thousand USD | -4068.206% |
| AVITA Medical, Inc. | 19.86 Million USD | -74.447% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1655.832% |
| Silk Road Medical, Inc | 114.15 Million USD | 69.643% |